FOUNDATION FOR RESEARCH IN INFECTIOUS DISEASES (EIN 942826726) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1986

Legal Domicile

Principal Officer

EMILY MARSH

Phone

4088675968

Tax Period

2023-03-01 to 2024-02-29

FOUNDATION FOR RESEARCH IN INFECTIOUS DISEASES, founded in 1986, is a micro nonprofit that reported $75K in total revenue in fiscal year 2023. Revenue fell 52% from the prior year — a significant decline worth monitoring. Expenses of $263K exceeded revenue, resulting in a 249% operating deficit.

Mission

FINANCIAL SUPPORT OF THE INFECTIOUS DISEASE RESEARCH LAB AT "CIMR."

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $13,276

Program Service Revenue $0

Investment Income $13,823

Other Revenue $48,270

TOTAL REVENUE $75,369

Expense Breakdown

Grants Paid $274,137

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $274,137

Other Expenses $-11,242

TOTAL EXPENSES $262,895

Year-over-Year Comparison

	2023	2022	Change
Revenue	$75,369	$158,592	-0.5%
Expenses	$262,895	$428,595	-0.4%
Net Income	$-187,526	$-270,003	-0.3%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Role	Reportable Comp	Other Comp	Total
EMILY MARSH	PRESIDENT	Officer Director	$0	$0	$0
PETER SANFORD	VICE-PRES	Officer Director	$0	$0	$0
JULIE STEVENS	SECRETARY/TREASURER	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$75,369	$262,895	$172,263	$-187,526
2023	$158,592	$428,595	$367,643	$-270,003
2022	$243,190	$460,584	$985,148	$-217,394
2021	$190,892	$588,513	$1,206,242	$-397,621
2020	$221,050	$501,919	$1,613,374	$-280,869
2019	$113,215	$443,837	$1,876,851	$-330,622

FOUNDATION FOR RESEARCH IN INFECTIOUS DISEASES